Johnson & Johnson

JNJ-N

NYSE:JNJ

149.17
0.97 (0.65%)
Johnson & Johnson is an American multinational medical devices, pharmaceutical and consumer packaged goods manufacturing company founded in 1886.
More at Wikipedia

Analysis and Opinions about JNJ-N

Signal
Opinion
Expert
WAIT
WAIT
February 7, 2006
He has a model price of $55.63 which is a negative differential of about 2%. It has to finish its downward run. He would wait until about $48.75/49 before buying.
Show full opinionHide full opinion
Johnson & Johnson (JNJ-N)
February 7, 2006
He has a model price of $55.63 which is a negative differential of about 2%. It has to finish its downward run. He would wait until about $48.75/49 before buying.
TOP PICK
TOP PICK
February 1, 2006
They were fighting with Boston Scientific (BSX-N) for an acquisition and lost. However, Boston Scientific has acquired a company larger than itself and will have to take on enormous debt and historically, these have turned out to be crippling deals.
Show full opinionHide full opinion
Johnson & Johnson (JNJ-N)
February 1, 2006
They were fighting with Boston Scientific (BSX-N) for an acquisition and lost. However, Boston Scientific has acquired a company larger than itself and will have to take on enormous debt and historically, these have turned out to be crippling deals.
BUY
BUY
January 31, 2006
Stock is down 9% over last year. All the big US pharmas are off a lot and this was the last one to fall. It has the best product range and does a very good job. He continues to like it.
Show full opinionHide full opinion
Johnson & Johnson (JNJ-N)
January 31, 2006
Stock is down 9% over last year. All the big US pharmas are off a lot and this was the last one to fall. It has the best product range and does a very good job. He continues to like it.
DON'T BUY
DON'T BUY
January 4, 2006
Seening a little more strength on the pharmaceutical side. He would still prefer to go to the generics.
Show full opinionHide full opinion
Seening a little more strength on the pharmaceutical side. He would still prefer to go to the generics.
BUY
BUY
November 8, 2005
Finds the valuation a little bit high relative to the growth rate. A strong brand name. You can buy this and put it away for a number of years. Very low risk.
Show full opinionHide full opinion
Johnson & Johnson (JNJ-N)
November 8, 2005
Finds the valuation a little bit high relative to the growth rate. A strong brand name. You can buy this and put it away for a number of years. Very low risk.
WAIT
WAIT
August 31, 2005
Sold off when it broke a technical signal in the early spring. Starting to look interesting at this price. Has a lot of free cash flow. It's only 50% pharmaceutical with the rest being consumer products. All the big pharmas are under pressure because of some hearings in the next few weeks.
Show full opinionHide full opinion
Sold off when it broke a technical signal in the early spring. Starting to look interesting at this price. Has a lot of free cash flow. It's only 50% pharmaceutical with the rest being consumer products. All the big pharmas are under pressure because of some hearings in the next few weeks.
BUY
BUY
June 22, 2005
This has not been a great environment in the last few years for drug stocks, but J&J has been an exception. A diversified medical company with all kinds of businesses. Has been the best performing drug stock and thinks it will continue to be.
Show full opinionHide full opinion
This has not been a great environment in the last few years for drug stocks, but J&J has been an exception. A diversified medical company with all kinds of businesses. Has been the best performing drug stock and thinks it will continue to be.
VAGUE
VAGUE
December 16, 2004
The only drug company they own and it is for the medical devices and for the consumer products rather than the pharmaceuticals.
Show full opinionHide full opinion
Johnson & Johnson (JNJ-N)
December 16, 2004
The only drug company they own and it is for the medical devices and for the consumer products rather than the pharmaceuticals.
VAGUE
VAGUE
November 10, 2004
Has the best fundamentals of all the drug stocks. Drug sector has come under a number of significant pressures.
Show full opinionHide full opinion
Johnson & Johnson (JNJ-N)
November 10, 2004
Has the best fundamentals of all the drug stocks. Drug sector has come under a number of significant pressures.
BUY
BUY
October 13, 2004
A great company. Feels the US$ will drop so there is a modest exchange risk.
Show full opinionHide full opinion
Johnson & Johnson (JNJ-N)
October 13, 2004
A great company. Feels the US$ will drop so there is a modest exchange risk.
BUY
BUY
September 14, 2004
May be considered boring, but the stability in terms of earnings is going to work well as a theme in the sector.
Show full opinionHide full opinion
Johnson & Johnson (JNJ-N)
September 14, 2004
May be considered boring, but the stability in terms of earnings is going to work well as a theme in the sector.
BUY
BUY
September 8, 2004
Widely diversified product line and not like normal pharmaceutical companies.
Show full opinionHide full opinion
Johnson & Johnson (JNJ-N)
September 8, 2004
Widely diversified product line and not like normal pharmaceutical companies.
TOP PICK
TOP PICK
July 23, 2004
A great business. Low valuation.
Show full opinionHide full opinion
A great business. Low valuation.
TOP PICK
TOP PICK
July 23, 2004
Good ballast for portfolios. Cheap valuation.
Show full opinionHide full opinion
Good ballast for portfolios. Cheap valuation.
TOP PICK
TOP PICK
July 15, 2004
2% yield. Didn't do much over the last year but is starting to recover with different products. On a valuation basis compared to their peers, they are at a much deeper discount. A safe investment.
Show full opinionHide full opinion
2% yield. Didn't do much over the last year but is starting to recover with different products. On a valuation basis compared to their peers, they are at a much deeper discount. A safe investment.
Showing 376 to 390 of 438 entries